Canadian evidence-based guideline for the first-line treatment of chronic lymphocytic leukemia

C. Owen, A. S. Gerrie, V. Banerji, S. Assouline, C. Chen, K. S. Robinson, E. Lye, G. Fraser

Abstract


Chronic lymphocytic leukemia (cll) is the most common adult leukemia in North America. In Canada, no unified national guideline exists for the front-line treatment of cll; provincial guidelines vary and are largely based on funding. A group of clinical experts from across Canada developed a national evidence-based treatment guideline to provide health care professionals with clear guidance on the first-line management of cll. Consensus recommendations based on available evidence are presented for the first-line treatment of cll.


Keywords


Chronic lymphocytic leukemia; cll; treatment; prognosis; fitness



DOI: http://dx.doi.org/10.3747/co.25.4092






Copyright © 2018 Multimed Inc.
ISSN: 1198-0052 (Print) ISSN: 1718-7729 (Online)